羧苄青霉素苯酯 | 27025-49-6

• 物质功能分类: 原料药 - 抗生素类药物 - 青霉素类药
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 羧苄青霉素苯酯
• 英文名称: carfecillin
• 英文别名: carbenicillin phenyl；6β-((Ξ)-2-phenoxycarbonyl-2-phenyl-acetylamino)-penicillanic acid；(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(3-oxo-3-phenoxy-2-phenylpropanoyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
• CAS: 27025-49-6
• 化学式: C₂₃H₂₂N₂O₆S
• 分子量: 454.503
• InChiKey: NZDASSHFKWDBBU-KVMCETHSSA-N

物化性质

• 沸点：
  770.9±60.0 °C(Predicted)
• 密度：
  1.2538 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  32
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  138
• 氢给体数：
  2
• 氢受体数：
  7

制备方法与用途

类别：有毒物质

• 毒性分级：中毒
• 急性毒性：
  • 腹腔注射（大鼠）LD50: 980毫克/公斤
  • 口服（小鼠）LD50: 3924毫克/公斤

可燃性危险特性：热分解时释放有毒的氮氧化物和硫氧化物烟雾

储运特性：库房应保持低温、通风干燥

灭火剂：水、二氧化碳、泡沫、干粉

反应信息

• 作为产物：
  描述：

  6-氨基青霉烷酸 、 苯基丙二酸单苯酯 生成 羧苄青霉素苯酯
  参考文献：
  名称：

  Preparation, hydrolysis, and oral absorption of .alpha.-carboxy esters of carbenicillin

  摘要：

  Twelve alpha-carboxy esters of carbenicillin, a parenteral broad spectrum semisynthetic penicillin, were synthesized and examined as potential oral carbenicillin derivatives. The rates at which the esters were hydrolyzed in vitro to carbenicillin by animal and human tissues were compared and the carbenicillin serum levels arising after oral administration of the esters were measured in squirrel monkeys and human volunteer subjects. The alpha-carboxyphenyl ester of carbenicillin [carfecillin (British Pharmacopoeia approved name), BRL 3475] WAS SELECTED FOR FURTHER STUDY AND IS PRESENTLY UNDERGOING CLInical trial.

  DOI：

  10.1021/jm00236a013

文献信息

• Kappa agonist compounds and pharmaceutical formulations thereof
  申请人：——

  公开号：US20030144272A1

  公开（公告）日：2003-07-31

  Compounds having kappa opioid agonist activity, compositions containing them and method of using them as analgesics are provided. The compounds of formulae I, II, IIA, III, IIIA, IIIB, IIIB-i, IV and IVA have the structure: 1 2 wherein R 1 , R 2 , R 3 , R 4 ; and X, X 4 , X 5 , X 7 , X 9 ; Y, Z and n are as described in the specification.

  提供具有kappa阿片受体激动剂活性的化合物，含有这些化合物的组合物以及使用它们作为镇痛剂的方法。 具有以下结构的化合物I、II、IIA、III、IIIA、IIIB、IIIB-i、IV和IVA： 1 2 其中 R 1 ，R 2 ，R 3 ，R 4 ；和 X，X 4 ，X 5 ，X 7 ，X 9 ； Y，Z和n如规范中所述。
• Carboxamide and amino derivatives and methods of their use
  申请人：Dolle E. Roland

  公开号：US20050113294A1

  公开（公告）日：2005-05-26

  Carboxamide and amino derivatives, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the carboxamide derivatives are ligands of the δ opioid receptor and are useful, inter alia, for treating and/or preventing pain, anxiety, gastrointestinal disorders, and other δ opioid receptor-mediated conditions.

  Carboxamide和氨基衍生物，含有这些化合物的药物组合物，以及其药用方法被披露。在某些实施例中，Carboxamide衍生物是δ阿片受体的配体，可用于治疗和/或预防疼痛、焦虑、胃肠道疾病和其他δ阿片受体介导的疾病。
• COMPOUNDS AND COMPOSITIONS FOR DRUG RELEASE
  申请人：INTERFACE BIOLOGICS, INC.

  公开号：US20160038651A1

  公开（公告）日：2016-02-11

  The invention relates to compounds that include biologically active agents (e.g., compounds according to any of formulas (I) and (I-A) that can be used for effective drug release, e.g., as coatings for medical devices. Use of these compounds in the coating of surfaces can allow for long-term drug release as well as imparting uniform coatings with little phase separation compared to, e.g., the parent biologically active agent.

  这项发明涉及包括生物活性剂（例如，根据任何公式（I）和（I-A）的化合物）的化合物，可用作有效的药物释放，例如，作为医疗器械的涂层。在表面涂层中使用这些化合物可以实现长期药物释放，并且与原生生物活性剂相比，可以实现均匀涂层且几乎没有相分离。
• OXIDATIVE COUPLING OF ARYL BORON REAGENTS WITH SP3-CARBON NUCLEOPHILES, AND AMBIENT DECARBOXYLATIVE ARYLATION OF MALONATE HALF-ESTERS VIA OXIDATIVE CATALYSIS
  申请人：The Governors of the University of Alberta

  公开号：US20180186721A1

  公开（公告）日：2018-07-05

  Described herein are methods of oxidative coupling of aryl boron reagents with sp 3 -carbon nucleophiles, and ambient decarboxylative arylation of malonate half-esters via oxidative catalysis.

  本文描述了一种利用氧化偶联芳基硼试剂与sp3-碳亲核试剂进行反应的方法，以及通过氧化催化实现马隆酸半酯的环境脱羧芳基化。
• POLYBASIC BACTERIAL EFFLUX PUMP INHIBITORS AND THERAPEUTIC USES THEREOF
  申请人：GLINKA TOMASZ

  公开号：US20080318957A1

  公开（公告）日：2008-12-25

  Disclosed are compounds having polybasic functionalities. The compounds inhibit bacterial efflux pump inhibitors and are used in combination with an anti-bacterial agent to treat or prevent bacterial infections. These combinations can be effective against bacterial infections that have developed resistance to anti-bacterial agents through an efflux pump mechanism.

  揭示了具有多元碱功能的化合物。这些化合物抑制细菌外流泵抑制剂，并与抗菌剂结合使用以治疗或预防细菌感染。这些组合物可以有效对抗通过外流泵机制对抗菌剂产生抗药性的细菌感染。